A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph+ ALL

• Uwe Rix ,

  Contributed equally to this work with: Uwe Rix, Jacques Colinge

  Current address: Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United Statse of America

  Affiliation CeMM – Research Center, Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  ⨯
• Jacques Colinge ,

  Contributed equally to this work with: Uwe Rix, Jacques Colinge

  Affiliation CeMM – Research Center, Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  ⨯
• Katharina Blatt,

  Affiliation Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

  ⨯
• Manuela Gridling,

  Affiliation CeMM – Research Center, Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  ⨯
• Lily L. Remsing Rix,

  Current address: Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United Statse of America

  Affiliation CeMM – Research Center, Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  ⨯
• Katja Parapatics,

  Affiliation CeMM – Research Center, Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  ⨯
• Sabine Cerny-Reiterer,

  Affiliations Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria, Ludwig Boltzmann Cluster Oncology, Vienna, Austria

  ⨯
• Thomas R. Burkard,

  Current address: IMBA - Institute for Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria

  Affiliation CeMM – Research Center, Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  ⨯
• Ulrich Jäger,

  Affiliation Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

  ⨯
• Junia V. Melo,

  Affiliations Department of Haematology, Centre for Cancer Biology, Adelaide, Australia, Imperial College London, London, United Kingdom

  ⨯
• Keiryn L. Bennett,

  Affiliation CeMM – Research Center, Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  ⨯
• Peter Valent,

  Affiliations Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria, Ludwig Boltzmann Cluster Oncology, Vienna, Austria

  ⨯
• Giulio Superti-Furga

  * E-mail: gsuperti@cemm.oeaw.ac.at

  Affiliation CeMM – Research Center, Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  ⨯